UBS Reiterates Buy on PulteGroup (PHM) Following Investor Meetings

September 19, 2016 9:09 AM EDT
Get Alerts PHM Hot Sheet
Price: $18.28 --0%

Rating Summary:
    11 Buy, 11 Hold, 5 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade PHM Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

UBS reiterated a Buy rating and $25.00 price target on PulteGroup (NYSE: PHM) following recent investor meetings with management. A recurring point in management’s dialogue is their dedication to driving profitability regardless of product type. However, with the appointment of Ryan Marshall to CEO and the addition of four new board members since 2Q, UBS believes that Pulte’s changes are behind it.

Analyst Susan Maklari commented, "Our recent investor meetings with Pulte management confirmed our belief that the company is well positioned to realize accelerated growth while furthering its commitment to shareholder returns. This includes the more recent evolution of Pulte’s Value Creation strategy—a key topic of conversation—under which it will moderate the rate of growth in land spend and allocate this cash flow to help fund $1.5bn of share repurchases through 2017. Additionally, as it has taken steps to reduce overhead, we expect this along with top-line unit expansion to drive greater operating leverage over the next 18-24 months. We are encouraged by the results to date and look for accelerated earnings growth given these company-specific factors, and a favorable operating environment, allowing for upside to the current valuation."

For an analyst ratings summary and ratings history on PulteGroup click here. For more ratings news on PulteGroup click here.

Shares of PulteGroup closed at $19.57 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments

Related Entities

UBS, Earnings

Add Your Comment